Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marjolijn Cj Jongmans

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
European Journal of Human Genetics : EJHG|August 13, 2016
Finding all BRCA pathogenic mutation carriers: best practice modelsNicoline Hoogerbrugge, Marjolijn Cj Jongmans
The Journal of Pathology|February 10, 2021
TRIM28 variants and Wilms' tumour predispositionJanna A Hol, Illja J Diets, Ronald R de Krijger, et al.
Elife|December 1, 2020
<i>TINF2</i> is a haploinsufficient tumor suppressor that limits telomere lengthIsabelle Schmutz, Arjen R Mensenkamp, Kaori K Takai, et al.
Nature Communications|May 14, 2025
Unraveling mutagenic processes influencing the tumor mutational patterns of individuals with constitutional mismatch repair deficiencyDilys D Weijers, Snežana Hinić, Emma Kroeze, et al.
BMJ Open|January 23, 2017
Validation of a clinical screening instrument for tumour predisposition syndromes in patients with childhood cancer (TuPS): protocol for a prospective, observational, multicentre studyFloor A M Postema, Saskia M J Hopman, Corianne A J M de Borgie, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
European Journal of Human Genetics : EJHG|August 13, 2016
Finding all BRCA pathogenic mutation carriers: best practice modelsNicoline Hoogerbrugge, Marjolijn Cj Jongmans
The Journal of Pathology|February 10, 2021
TRIM28 variants and Wilms' tumour predispositionJanna A Hol, Illja J Diets, Ronald R de Krijger, et al.
Elife|December 1, 2020
<i>TINF2</i> is a haploinsufficient tumor suppressor that limits telomere lengthIsabelle Schmutz, Arjen R Mensenkamp, Kaori K Takai, et al.
Nature Communications|May 14, 2025
Unraveling mutagenic processes influencing the tumor mutational patterns of individuals with constitutional mismatch repair deficiencyDilys D Weijers, Snežana Hinić, Emma Kroeze, et al.
BMJ Open|January 23, 2017
Validation of a clinical screening instrument for tumour predisposition syndromes in patients with childhood cancer (TuPS): protocol for a prospective, observational, multicentre studyFloor A M Postema, Saskia M J Hopman, Corianne A J M de Borgie, et al.
Pageof 1